NCT04263480
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04263480
Title Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia (CZAR-1)
Acronym CZAR-1
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Christian Buske
Indications
Therapies
Age Groups: adult | senior
Covered Countries GRC | DEU | AUT

Facility Status City State Zip Country Details
Uniklinikum Salzburg Salzburg 5020 Austria Details
Medizinische Universität Wien Vienna 1090 Austria Details
Vivantes Klinikum am Urban Berlin 10967 Germany Details
Ev. Diakoniekrankenhaus Bremen 28239 Germany Details
Kath. St.-Johannes-Gesellschaft Dortmund gGmbH Dortmund 44137 Germany Details
Gemeinschaftspraxis Mohm / Prange-Krex Dresden 01307 Germany Details
OncoResearch Lerchenfeld GmbH Hamburg 22081 Germany Details
MediProject Onkologisches Ambulanzzentrum Hannover Hanover 30171 Germany Details
Praxis für Hämatologie und Onkologie, onkologische Tagesklinik-VK&K Studien GbR Landshut 84036 Germany Details
Praxis Dr. Vehling-Kaiser Landshut 84130 Germany Details
Rotkreuzklinikum München Munich 80634 Germany Details
Hämatologie/Onkologie München Pasing MVZ GmbH Munich 81241 Germany Details
Kliniken Ostalb, Staufenklinikum Schw. Gmuend Mutlangen 72557 Germany Details
Friedrich-Ebert-Krankenhaus Neumünster 24534 Germany Details
Bruederkrankenhaus St. Josef Paderborn 33098 Germany Details
Universitätsmedizin Rostock Rostock 18055 Germany Details
Klinikum Mutterhaus Mitte Trier gGmbh Studienzentrum Trier 54290 Germany Details
University Hospital Ulm Ulm 89081 Germany Details
Hämatologisch-Onkologische Schwerpunktpraxis Drs. Schöttker & Pretscher Würzburg 97080 Germany Details
Alexandra Hospital Athens 11528 Greece Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field